Published in Eur J Surg Oncol on May 11, 2007
Salivary analysis of oral cancer biomarkers. Br J Cancer (2009) 1.29
Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression. Cancers (Basel) (2014) 1.10
Fluctuating roles of matrix metalloproteinase-9 in oral squamous cell carcinoma. ScientificWorldJournal (2013) 0.97
Genetic polymorphisms of matrix metalloproteinases and their inhibitors in potentially malignant and malignant lesions of the head and neck. J Biomed Sci (2010) 0.95
An insight into salivary markers in oral cancer. Dent Res J (Isfahan) (2013) 0.84
Meta-analysis of MMP2, MMP3, and MMP9 promoter polymorphisms and head and neck cancer risk. PLoS One (2013) 0.84
Matrix metalloproteinase gene polymorphisms and oral cancer. J Clin Exp Dent (2012) 0.83
Association of (-1,607) 1G/2G polymorphism of matrix metalloproteinase-1 gene with knee osteoarthritis in the Turkish population (knee osteoarthritis and MMPs gene polymorphisms). Rheumatol Int (2008) 0.81
Prognostic value of matrix metalloproteinases in oral squamous cell carcinoma. Biotechnol Biotechnol Equip (2014) 0.77
Future Imaging Alternatives: The Clinical Non-invasive Modalities in Diagnosis of Oral Squamous Cell Carcinoma (OSCC). Open Dent J (2015) 0.76
Current concepts and future of noninvasive procedures for diagnosing oral squamous cell carcinoma--a systematic review. Head Face Med (2015) 0.76
Impact of matrix metalloproteinase 9 rs3918242 genetic variant on lipid-lowering efficacy of simvastatin therapy in Chinese patients with coronary heart disease. BMC Pharmacol Toxicol (2017) 0.75
Serum and salivary levels of chemerin and MMP-9 in oral squamous cell carcinoma and oral premalignant lesions. Clin Oral Investig (2016) 0.75
Active immunization with pC protein of Borrelia burgdorferi protects gerbils against B. burgdorferi infection. Infection (1993) 2.89
Isolation of temperature-sensitive mutants of 16 S rRNA in Escherichia coli. J Mol Biol (1989) 1.82
Morbidity of harvesting of bone grafts from the iliac crest for preprosthetic augmentation procedures: a prospective study. Int J Oral Maxillofac Surg (2004) 1.76
Morbidity of harvesting of chin grafts: a prospective study. Clin Oral Implants Res (2001) 1.49
Serum levels of E-selectin, ICAM-1 and VCAM-1 in colorectal cancer patients: correlations with clinicopathological features, patient survival and tumour surgery. Eur J Cancer (2001) 1.27
Hepatoid adenocarcinoma of the gallbladder. Dig Dis Sci (2007) 1.25
Head and neck tumors: imaging recurrent tumor and post-therapeutic changes with CT and MRI. Eur J Radiol (2000) 1.24
Bone regeneration in critical size defects by cell-mediated BMP-2 gene transfer: a comparison of adenoviral vectors and liposomes. Gene Ther (2003) 1.23
Prospective study on post-traumatic and postoperative sensory disturbances of the inferior alveolar nerve and infraorbital nerve in mandibular and midfacial fractures. J Craniomaxillofac Surg (1999) 1.21
c-FLIP expression in colorectal carcinomas: association with Fas/FasL expression and prognostic implications. Histopathology (2007) 1.20
Structure of astacin with a transition-state analogue inhibitor. Nat Struct Biol (1996) 1.17
Prognostic evaluation of the microvascular network in myelodysplastic syndromes. Leukemia (2001) 1.16
Nuclear fractal dimension as a prognostic factor in oral squamous cell carcinoma. Oral Oncol (2007) 1.15
Persistence of Borrelia burgdorferi and histopathological alterations in experimentally infected animals. A comparison with histopathological findings in human Lyme disease. Infection (1991) 1.13
Hypersensitivity reactions to carboplatin administration are common but not always severe: a 10-year experience. Oncology (2001) 1.12
Hypoxia-inducible factor 1alpha/vascular endothelial growth factor axis in astrocytomas. Associations with microvessel morphometry, proliferation and prognosis. Neuropathol Appl Neurobiol (2004) 1.10
How a neuropsychiatric brain bank should be run: a consensus paper of Brainnet Europe II. J Neural Transm (Vienna) (2006) 1.07
The prognostic value of PTEN, p53, and beta-catenin in endometrial carcinoma: a prospective immunocytochemical study. Int J Gynecol Cancer (2007) 1.06
Prognostic role of pretreatment plasma fibrinogen in patients with solid tumors: A systematic review and meta-analysis. Cancer Treat Rev (2015) 1.05
Radiochemotherapy induces a favourable tumour infiltrating inflammatory cell profile in head and neck cancer. Oral Oncol (2012) 1.04
Harvesting of bone from the iliac crest--comparison of the anterior and posterior sites. Br J Oral Maxillofac Surg (2005) 1.03
The hamster model of sequential oral oncogenesis. Oral Oncol (2007) 1.01
Morphometric microvascular characteristics predict prognosis in superficial and invasive bladder cancer. Virchows Arch (2001) 0.99
RXP 407, a phosphinic peptide, is a potent inhibitor of angiotensin I converting enzyme able to differentiate between its two active sites. Proc Natl Acad Sci U S A (1999) 0.98
Highly increased CSF tau protein and decreased beta-amyloid (1-42) in sporadic CJD: a discrimination from Alzheimer's disease? J Neurol Neurosurg Psychiatry (2001) 0.97
Joseph Gensoul's operation for sarcoma of the maxillary antrum, one century before Moore. J BUON (2013) 0.97
Pyothorax-associated lymphoma (PAL): a western case with marked angiocentricity and review of the literature. Histopathology (2004) 0.96
RXP 407, a selective inhibitor of the N-domain of angiotensin I-converting enzyme, blocks in vivo the degradation of hemoregulatory peptide acetyl-Ser-Asp-Lys-Pro with no effect on angiotensin I hydrolysis. J Pharmacol Exp Ther (2001) 0.96
Orbital involvement in cherubism. Ophthalmology (2001) 0.95
Association of oestrogen receptor alpha polymorphisms and androgen receptor CAG trinucleotide repeats with male infertility: a study in 109 Greek infertile men. Int J Androl (2002) 0.95
Long-term results of distraction osteogenesis of the maxilla and midface. Br J Oral Maxillofac Surg (2002) 0.94
Angiogenesis in Hodgkin's lymphoma: a morphometric approach in 286 patients with prognostic implications. Leukemia (2005) 0.94
Hypoxaemic reperfusion ameliorates the histopathological changes in the pig brain after a severe global cerebral ischaemic insult. Intensive Care Med (2001) 0.94
Clinical and genetic heterogeneity in benign hereditary chorea. Neurology (2002) 0.93
Prognostic implications of microvessel morphometry in diffuse astrocytic neoplasms. Neuropathol Appl Neurobiol (2002) 0.93
pERK activation in esophageal carcinomas: clinicopathological associations. Pathol Res Pract (2012) 0.93
Influence of pore dimensions on bone ingrowth into porous hydroxylapatite blocks used as bone graft substitutes. A histometric study. Int J Oral Maxillofac Surg (1991) 0.92
Acute appendicitis: the reliability of diagnosis by clinical assessment alone. Scand J Surg (2005) 0.92
Correlation between different p53 expression patterns and chromosome 17 imbalances in pancreatic ductal adenocarcinoma based on tissue microarray analysis. J BUON (2010) 0.92
Caspase-3 immunohistochemical expression is a marker of apoptosis, increased grade and early recurrence in intracranial meningiomas. Apoptosis (2006) 0.92
Langerhans cell granulomatosis: a case report of polyostotic manifestation in the jaw. Int J Oral Maxillofac Surg (2001) 0.92
Hertel exophthalmometry versus computed tomography and optical 3D imaging for the determination of the globe position in zygomatic fractures. Int J Oral Maxillofac Surg (2004) 0.91
The interleukin-8 (-251A/T) polymorphism is associated with increased risk for oral squamous cell carcinoma. Eur J Surg Oncol (2006) 0.91
Phosphinic peptides, the first potent inhibitors of astacin, behave as extremely slow-binding inhibitors. Biochem J (1998) 0.90
Evaluation of the incorporation of bone grafts used in maxillofacial surgery with [18F]fluoride ion and dynamic positron emission tomography. Eur J Nucl Med (1995) 0.90
Exercise renal rehabilitation program: psychosocial effects. Nephron (1997) 0.90
Long-term quality of life after ablative intraoral tumour surgery. J Craniomaxillofac Surg (1995) 0.90
Effects of distraction forces and frequency of distraction on bony regeneration. Br J Oral Maxillofac Surg (2005) 0.89
Clinicopathologic correlations of bone marrow angiogenesis in chronic myeloid leukemia: a morphometric study. Leukemia (2003) 0.89
Plasminogen activator inhibitor-1 polymorphism is associated with increased risk for oral cancer. Oral Oncol (2006) 0.89
The effect on bone regeneration of a liposomal vector to deliver BMP-2 gene to bone grafts in peri-implant bone defects. Biomaterials (2007) 0.89
A prospective electromyographic and computer-aided thermal sensitivity assessment of nerve lesions after sagittal split osteotomy and Le Fort I osteotomy. J Oral Maxillofac Surg (2001) 0.88
Liver histology alterations during carbon dioxide pneumoperitoneum in a porcine model. Surg Endosc (2008) 0.88
Continuous and intermittent bone distraction using a microhydraulic cylinder: an experimental study in minipigs. Br J Oral Maxillofac Surg (2001) 0.88
Secreted phosphoprotein-1 directly provokes vascular leakage to foster malignant pleural effusion. Oncogene (2012) 0.88
A new distraction device to compare continuous and discontinuous bone distraction in mini-pigs: a preliminary report. J Craniomaxillofac Surg (2000) 0.87
Bone scintigraphy in the evaluation of bone grafts used for mandibular reconstruction. Eur J Nucl Med (1994) 0.87
Sarcomas of the head and neck. Results from the treatment of 25 patients. Eur J Surg Oncol (2005) 0.87
Common carotid artery occlusion treatment: revealing a gap in the current guidelines. Eur J Vasc Endovasc Surg (2013) 0.87
Metal release from titanium fixtures during placement in the mandible: an experimental study. Int J Oral Maxillofac Implants (1993) 0.86
Onlay augmentation versus sinuslift procedure in the treatment of the severely resorbed maxilla: a 5-year comparative longitudinal study. Int J Oral Maxillofac Surg (2005) 0.86
Increased incidence of sporadic Creutzfeldt-Jakob disease on the island of Crete associated with a high rate of PRNP 129-methionine homozygosity in the local population. Ann Neurol (2001) 0.86
The value of TOP2A, EZH2 and paxillin expression as markers of aggressive breast cancer: relationship with other prognostic factors. Eur J Gynaecol Oncol (2011) 0.86
[Postoperative monitoring of microvascular flap repair with pulse oximetry--initial experience]. Handchir Mikrochir Plast Chir (1994) 0.86
Increased angiogenesis and mast cells in the centre compared to the periphery of vitiligo lesions. Arch Dermatol Res (2010) 0.86
Methylenetetrahydrofolate reductase polymorphism and minor increase of risk for oral cancer. J Cancer Res Clin Oncol (2005) 0.85
Subacute necrotizing encephalomyelopathy (Leigh's disease): a clinicopathologic study of ten cases. Gen Diagn Pathol (1997) 0.85
Analysis of PIK3CA and B-RAF gene mutations in human astrocytomas: association with activation of ERK and AKT. Clin Neuropathol (2010) 0.85
A simple and effective approach for detecting maternal cell contamination in molecular prenatal diagnosis. Prenat Diagn (2002) 0.85
Use of truncated pyramid representation methodology in three-dimensional reconstruction: an example. J Microsc (2004) 0.85
Prognostic impact of HER2/neu protein in urothelial bladder cancer. Survival analysis of 80 cases and an overview of almost 20 years' research. J BUON (2009) 0.85
[Surgical management of obstructive sleep apnea]. Mund Kiefer Gesichtschir (2007) 0.85
Myoepithelial carcinoma of the parotid gland. Malays J Pathol (2014) 0.85
Heregulin, cysteine rich-61 and matrix metalloproteinase 9 expression in human carotid atherosclerotic plaques: relationship with clinical data. Eur J Vasc Endovasc Surg (2006) 0.85
Apoptotic markers for primary brain tumor prognosis. J Neurooncol (2005) 0.85
Improvement of skin-graft survival after autologous transplantation of adipose-derived stem cells in rats. J Plast Reconstr Aesthet Surg (2011) 0.84
Gene polymorphisms related to angiogenesis, inflammation and thrombosis that influence risk for oral cancer. Oral Oncol (2008) 0.84